MODIFICATION TO VIGIL LIPID CONTROL— 510(k) K020521

Substantially Equivalent

Beckman Coulter, Inc.

FDA 510(k) clearance K020521 for MODIFICATION TO VIGIL LIPID CONTROL, Substantially Equivalent on 2002-03-01. Applicant: Beckman Coulter, Inc..

Clearance details

Applicant: Beckman Coulter, Inc.
Product code: Code JJY
Advisory panel: Clinical Chemistry
Date received: 2002-02-19
Decision date: 2002-03-01
Decision: Substantially Equivalent
Clearance type: Special
Location: Brea, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.